TEMPLETON EMERGING MARKETS (EMF) Fundamental Analysis & Valuation

NYSE:EMF • US8801911012

Current stock price

18.91 USD
+1.12 (+6.3%)
Last:

This EMF fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. EMF Profitability Analysis

1.1 Basic Checks

  • EMF had positive earnings in the past year.
  • EMF had a positive operating cash flow in the past year.
  • EMF had positive earnings in 4 of the past 5 years.
  • EMF had a positive operating cash flow in 4 of the past 5 years.
EMF Yearly Net Income VS EBIT VS OCF VS FCFEMF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M

1.2 Ratios

Industry RankSector Rank
ROA 18.95%
ROE 19.61%
ROIC 1.03%
ROA(3y)12.73%
ROA(5y)3.66%
ROE(3y)13.24%
ROE(5y)3.27%
ROIC(3y)1.48%
ROIC(5y)1.28%
EMF Yearly ROA, ROE, ROICEMF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

1.3 Margins

  • EMF's Profit Margin has improved in the last couple of years.
  • In the last couple of years the Operating Margin of EMF has grown nicely.
  • EMF's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 52.74%
PM (TTM) 771.19%
GM 53.96%
OM growth 3Y-1.43%
OM growth 5Y7.07%
PM growth 3YN/A
PM growth 5Y3.05%
GM growth 3Y-1.31%
GM growth 5Y6.4%
EMF Yearly Profit, Operating, Gross MarginsEMF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. EMF Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for EMF remains at a similar level compared to 1 year ago.
  • EMF has less shares outstanding than it did 5 years ago.
  • EMF has a better debt/assets ratio than last year.
EMF Yearly Shares OutstandingEMF Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
EMF Yearly Total Debt VS Total AssetsEMF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • EMF has an Altman-Z score of 17.97. This indicates that EMF is financially healthy and has little risk of bankruptcy at the moment.
  • The Debt to FCF ratio of EMF is 0.10, which is an excellent value as it means it would take EMF, only 0.10 years of fcf income to pay off all of its debts.
  • A Debt/Equity ratio of 0.02 indicates that EMF is not too dependend on debt financing.
  • Although EMF's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.1
Altman-Z 17.97
ROIC/WACCN/A
WACCN/A
EMF Yearly LT Debt VS Equity VS FCFEMF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • EMF has a Current Ratio of 1.04. This is a normal value and indicates that EMF is financially healthy and should not expect problems in meeting its short term obligations.
  • A Quick Ratio of 1.04 indicates that EMF should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 1.04
EMF Yearly Current Assets VS Current LiabilitesEMF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M 5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. EMF Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 76.44% over the past year.
  • The Earnings Per Share has been growing slightly by 5.15% on average over the past years.
  • Looking at the last year, EMF shows a very negative growth in Revenue. The Revenue has decreased by -11.71% in the last year.
  • EMF shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.43% yearly.
EPS 1Y (TTM)76.44%
EPS 3YN/A
EPS 5Y5.15%
EPS Q2Q%91.78%
Revenue 1Y (TTM)-11.71%
Revenue growth 3Y-8.96%
Revenue growth 5Y0.43%
Sales Q2Q%-13.35%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMF Yearly Revenue VS EstimatesEMF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

More info and screens

Find the best growth stocksShow best growing peers

2

4. EMF Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 5.61, which indicates a rather cheap valuation of EMF.
  • Compared to an average S&P500 Price/Earnings ratio of 26.21, EMF is valued rather cheaply.
Industry RankSector Rank
PE 5.61
Fwd PE N/A
EMF Price Earnings VS Forward Price EarningsEMF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 5.65
EV/EBITDA N/A
EMF Per share dataEMF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.09
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. EMF Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 9.34%, EMF is a good candidate for dividend investing.
  • Compared to an average S&P500 Dividend Yield of 1.89, EMF pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.34%

5.2 History

  • The dividend of EMF decreases each year by -4.11%.
  • EMF has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of EMF decreased recently.
Dividend Growth(5Y)-4.11%
Div Incr Years1
Div Non Decr Years1
EMF Yearly Dividends per shareEMF Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 27.67% of the earnings are spent on dividend by EMF. This is a low number and sustainable payout ratio.
DP27.67%
EPS Next 2YN/A
EPS Next 3YN/A
EMF Yearly Income VS Free CF VS DividendEMF Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M
EMF Dividend Payout.EMF Dividend Payout, showing the Payout Ratio.EMF Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EMF Fundamentals: All Metrics, Ratios and Statistics

TEMPLETON EMERGING MARKETS

NYSE:EMF (4/8/2026, 2:41:38 PM)

18.91

+1.12 (+6.3%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)04-29
Inst Owners68.59%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap282.70M
Revenue(TTM)6.56M
Net Income(TTM)50.59M
Analysts0
Price TargetN/A
Short Float %0.07%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield 9.34%
Yearly Dividend0.93
Dividend Growth(5Y)-4.11%
DP27.67%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-24
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.61
Fwd PE N/A
P/S 43.1
P/FCF 5.65
P/OCF 5.65
P/B 1.1
P/tB 1.1
EV/EBITDA N/A
EPS(TTM)3.37
EY17.82%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)3.34
FCFY17.69%
OCF(TTM)3.34
OCFY17.69%
SpS0.44
BVpS17.25
TBVpS17.25
PEG (NY)N/A
PEG (5Y)1.09
Graham Number36.16
Profitability
Industry RankSector Rank
ROA 18.95%
ROE 19.61%
ROCE 1.31%
ROIC 1.03%
ROICexc 1.03%
ROICexgc 1.03%
OM 52.74%
PM (TTM) 771.19%
GM 53.96%
FCFM 762.2%
ROA(3y)12.73%
ROA(5y)3.66%
ROE(3y)13.24%
ROE(5y)3.27%
ROIC(3y)1.48%
ROIC(5y)1.28%
ROICexc(3y)1.48%
ROICexc(5y)1.28%
ROICexgc(3y)1.48%
ROICexgc(5y)1.28%
ROCE(3y)1.87%
ROCE(5y)1.62%
ROICexgc growth 3Y-12.87%
ROICexgc growth 5Y10.25%
ROICexc growth 3Y-12.87%
ROICexc growth 5Y10.25%
OM growth 3Y-1.43%
OM growth 5Y7.07%
PM growth 3YN/A
PM growth 5Y3.05%
GM growth 3Y-1.31%
GM growth 5Y6.4%
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.1
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 98.83%
Current Ratio 1.04
Quick Ratio 1.04
Altman-Z 17.97
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)100%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.44%
EPS 3YN/A
EPS 5Y5.15%
EPS Q2Q%91.78%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.71%
Revenue growth 3Y-8.96%
Revenue growth 5Y0.43%
Sales Q2Q%-13.35%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21%
EBIT growth 3Y-10.26%
EBIT growth 5Y7.53%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y72.41%
FCF growth 3YN/A
FCF growth 5Y3.5%
OCF growth 1Y72.41%
OCF growth 3YN/A
OCF growth 5Y3.5%

TEMPLETON EMERGING MARKETS / EMF Fundamental Analysis FAQ

What is the fundamental rating for EMF stock?

ChartMill assigns a fundamental rating of 3 / 10 to EMF.


What is the valuation status for EMF stock?

ChartMill assigns a valuation rating of 2 / 10 to TEMPLETON EMERGING MARKETS (EMF). This can be considered as Overvalued.


How profitable is TEMPLETON EMERGING MARKETS (EMF) stock?

TEMPLETON EMERGING MARKETS (EMF) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for EMF stock?

The Price/Earnings (PE) ratio for TEMPLETON EMERGING MARKETS (EMF) is 5.61 and the Price/Book (PB) ratio is 1.1.